Hologic Makes Good On Mobidiag Acquisition With Expanded Launch Of Diagnostics Platform
Following the purchase of Mobidiag, Hologic has aggressively launched the Novodiag platform across Europe in a bid to dominate the local molecular diagnostics market.
You may also be interested in...
Mobidiag develops molecular diagnostic tests and instrumentation that will expand Hologic’s acute care testing capabilities.
Hologic made its third big acquisition of 2021 and Agilent agreed to pay up to $695m for Resolution Bioscience to extend its precision oncology capabilities.
Hologic’s recent buy-outs put it in a strengthened growth and competitive position beyond COVID.